Inpatient BMT Medical Director/BMT Fellowship Director
Moffitt Cancer Center
Pediatric Hematology & Oncology
Dr. Michael L. Nieder, MD
Dr. Michael L. Nieder is an expert in the field of Pediatric Hematology & Oncology. He researched medicine at University of Illinois College of Medicine. He over the years received 5 awards: "Member", "Americas Top Doctors for Cancer", "Most Recommended Physican", "Cancer Care Hall of Fame" and "Kaiser Permanente Clinical Faculty Teacher of the Year". Michael L. Nieder, MD is a published doctor as well. He has 27 publications published. The latest was: Additional chemotherapy agents improve treatment outcome for children and adults with advanced B-cell lymphomas.
Publications
- The safety and feasibility of probiotics in children and adolescents undergoing hematopoietic Cell transplantation.
- Using Fludarabine to Reduce Exposure to Alkylating Agents in Children with Sickle Cell Disease Receiving Busulfan, Cyclophosphamide, and Antithymocyte Globulin Transpl...
- Pharmacokinetically-targeted BU and fludarabine as conditioning before allogeneic hematopoietic Cell transplantation for adults with ALL in first remission.
- A pilot study of low-dose anti-angiogenic chemotherapy in combination with standard multiagent chemotherapy for patients with newly diagnosed metastatic Ewing sarcoma ...
- National Cancer Institute, National Heart, Lung and Blood Institute/Pediatric Blood and Marrow Transplantation Consortium First International Consensus Conference on L...
- National Cancer Institute-National Heart, Lung and Blood Institute First International Consensus Conference on Late Effects After Pediatric Hematopoietic Cell Transpla...
- Advancement of pediatric blood and marrow transplantation research in North America: priorities of the Pediatric Blood and Marrow Transplant Consortium.
- Single copies of the N-myc oncogene in neuroblastomas from children presenting with the syndrome of opsoclonus-myoclonus.
- Severe atypical neuropathy associated with administration of hematopoietic colony-stimulating factors and vincristine.
- Successful large volume leukapheresis on a small infant allogeneic donor.
- A double-blind randomized placebo-controlled study of oral glutamine in the prevention of mucositis in children undergoing hematopoietic stem Cell transplantation: a p...
- Infections in children with Cancer: a continued need for the comprehensive physical examination.
- Additional chemotherapy agents improve treatment outcome for children and adults with advanced B-cell Lymphomas.
- Psychosocial supportive care for children receiving stem Cell transplantation: practice patterns across centers.
- Adults and children with small non-cleaved-cell Lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen.
- Excessive spinal cord toxicity from intensive central nervous system-directed therapies.
- Allogeneic mesenchymal stem Cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH).
- Trends in clinical practice and nurses' attitudes about fertility preservation for pediatric patients with Cancer.
- Pediatric oncology nurses' attitudes related to discussing fertility preservation with pediatric Cancer patients and their families.
- Barriers to fertility preservation among pediatric oncologists.
- NCI, NHLBI first international consensus conference on late effects after pediatric hematopoietic Cell transplantation: state of the science, future directions.
- Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children''s Oncology Group.
- Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate.
- Safety, efficacy, and pharmacokinetics of intravenous busulfan in children undergoing allogeneic hematopoietic stem Cell transplantation.
- Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma: a report from the Children''s Oncology Group.
- Are matched unrelated donor transplants justified for AML in CR1?
Schools
University Of Illinois College Of Medicine Chicago
Children39s Memorial Hospital
Procedures Preformed
- Bone Marrow Transplant
- HPC Transplantation (Stem Cell Transplant)
Conditions Treated
- Acute Leukemia
- Anemia
- Coagulation Disorders (incl. Hemophilia)
- Graft vs Host Disease
- View All
Doctors Specialties
- Pediatric Hematology
- Oncology
Accepted Insurances
Awards
- Member
- America’s Top Doctors for Cancer
- Most Recommended Physican
- Cancer Care Hall of Fame
- Kaiser Permanente Clinical Faculty Teacher of the Year
Education
-
University of Illinois College of Medicine
Hospital
-
H. Lee Moffitt Cancer Center and Research Institute
Helpful Reviews
Give
Anonymous Review
Medicare Facts
| National Provider Identifier [NPI] |
1295710218 |
| Last Name Of The Provider |
NIEDER |
| First Name Of The Provider |
MICHAEL |
| View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog
This Doctor is OpenDoctor Recommended.
